SECAUCUS, N.J., Aug. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on October 20, 2025 to shareholders of record of Quest...
Related Questions
Could the dividend announcement trigger any changes in the stock's options implied volatility or open interest?
What is the ex‑dividend date and how might it influence short‑term trading volume?
How does this dividend declaration compare to DGX's historical payout trends and growth rate?
What are the company's earnings and cash flow fundamentals supporting this dividend level?
How does Quest Diagnostics' dividend yield compare to peer diagnostic and healthcare companies?
Will the dividend signal confidence in the company's future cash generation or simply a financial engineering move?
How will the $0.80 quarterly dividend affect Quest Diagnostics' share price and yield expectations?
Are there any indications that the dividend could be increased, maintained, or cut in upcoming quarters?
How might this dividend declaration impact institutional investors' holding strategies for DGX?
What is the payout ratio based on the latest earnings, and is it sustainable?